Nuclear factor erythroid-2-related factor 2 (Nrf2) is a stress-activated transcription factor regulating antioxidant genes, and a deficiency thereof, slowing lymphangiogenesis, has been reported in diabetic foot ulcer (DFU). The mode ofNrf2regulation in DFU has been less explored. Emerging studies on miRNA-mediated target regulation show miRNA to be the leading player in the pathogenesis of the disease. In the present study, we demonstrated the role of miR-27b in regulatingNrf2-mediated angiogenesis in DFU. A lower expression of mRNA targets, such asNrf2,HO-1,SDF-1α, andVEGF, was observed in tissue biopsied from chronic DFU subjects, which was in line with miR-27b, signifying a positive correlation withNrf2. Similarly, we found significantly reduced expression of miR-27b and target mRNAsNrf2,HO-1,SDF-1α, andVEGFin endothelial cells under a hyperglycemic microenvironment (HGM). To confirm the association of miR-27b on regulatingNrf2-mediated angiogenesis, we inhibited its expression through RNA interference-mediated knockdown and observed disturbances in angiogenic signaling with reduced endothelial cell migration. In addition, to explore the role of miR-27b and angiogenesis in the activation ofNrf2, we pretreated the endothelial cells with two well-known pharmacological compounds—pterostilbene and resveratrol. We observed that activation ofNrf2through these compounds ameliorates impaired angiogenesis on HGM-induced endothelial cells. This study suggests a positive role of miR-27b in regulatingNrf2, which seems to be decreased in DFU and improves on treatment with pterostilbene and resveratrol.